These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29391134)

  • 1. Lipemic interference of ceruloplasmin assays - An evaluation of lipid removal methods.
    Hunsaker JJH; La'ulu SL; Wyness SP; Genzen JR
    Clin Chim Acta; 2018 May; 480():71-78. PubMed ID: 29391134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of L-index interference limits on Roche cobas c502 and c702 immunoturbidimetric assays using endogenously lipemic specimens and intralipid spiking.
    Hunsaker JJH; Wyness SP; Needham LL; Genzen JR
    Clin Biochem; 2019 Aug; 70():18-23. PubMed ID: 31145903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation and comparison of consecutive high speed centrifugation and LipoClear® reagent for lipemia removal.
    Saracevic A; Nikolac N; Simundic AM
    Clin Biochem; 2014 Mar; 47(4-5):309-14. PubMed ID: 24434304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing pseudohyponatremia: Intralipid®-based lipemia cutoffs for sodium are inappropriate.
    Koch CD; Vera MA; Messina J; Price N; Durant TJS; El-Khoury JM
    Clin Chim Acta; 2021 Sep; 520():63-66. PubMed ID: 34077753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of interference from hemolysis, icterus and lipemia on routine pediatric clinical chemistry assays.
    Agarwal S; Vargas G; Nordstrom C; Tam E; Buffone GJ; Devaraj S
    Clin Chim Acta; 2015 Jan; 438():241-5. PubMed ID: 25128720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancies in Lipemia Interference Between Endogenous Lipemic Samples and Smoflipid
    Fernández-Prendes C; Castro-Castro MJ; Jiménez-Añón L; Morales-Indiano C; Martínez-Bujidos M
    EJIFCC; 2023 Apr; 34(1):27-41. PubMed ID: 37124657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of lipemia acceptance thresholds for 31 immunoassay analytes.
    Ercan Ş; Tat M
    Clin Chim Acta; 2023 Aug; 548():117508. PubMed ID: 37572842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision, accuracy, cross reactivity and comparability of serum indices measurement on Abbott Architect c8000, Beckman Coulter AU5800 and Roche Cobas 6000 c501 clinical chemistry analyzers.
    Nikolac Gabaj N; Miler M; Vrtarić A; Hemar M; Filipi P; Kocijančić M; Šupak Smolčić V; Ćelap I; Šimundić AM
    Clin Chem Lab Med; 2018 Apr; 56(5):776-788. PubMed ID: 29315074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipemia: causes, interference mechanisms, detection and management.
    Nikolac N
    Biochem Med (Zagreb); 2014; 24(1):57-67. PubMed ID: 24627715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Method of Lipemia Clearance Should be Based on the Characteristics and the Method of Testing in the Emergency Laboratory.
    Zhu JH; Lan XH; Liang XM; Zhang JW; Cai MJ; Zhuang YL; Sun HZ; Dai Z
    Clin Lab; 2024 Aug; 70(8):. PubMed ID: 39193976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removing Lipemia in Serum/Plasma Samples: A Multicenter Study.
    Castro-Castro MJ; Candás-Estébanez B; Esteban-Salán M; Calmarza P; Arrobas-Velilla T; Romero-Román C; Pocoví-Mieras M; Aguilar-Doreste JÁ;
    Ann Lab Med; 2018 Nov; 38(6):518-523. PubMed ID: 30027694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of patient results for Beckman Coulter LX-20 assays affected by interference due to hemoglobin, bilirubin or lipids: a practical approach.
    Vermeer HJ; Steen G; Naus AJ; Goevaerts B; Agricola PT; Schoenmakers CH
    Clin Chem Lab Med; 2007; 45(1):114-9. PubMed ID: 17243928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a third party enzymatic ammonia method for use on the Roche Cobas 6000 (c501) automated platform.
    Seiden-Long I; Schnabl K; Skoropadyk W; Lennon N; McKeage A
    Clin Biochem; 2014 Aug; 47(12):1116-20. PubMed ID: 24792455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of marked hypertriglyceridemia and lipid clearance techniques on canine biochemistry testing.
    Azevedo CN; Lidbury JA; Jeffery U
    J Vet Diagn Invest; 2019 Jul; 31(4):546-553. PubMed ID: 31238801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of manufacturers' declarations for lipemia interference--an urgent call for standardization.
    Nikolac N; Simundic AM; Miksa M; Lima-Oliveira G; Salvagno GL; Caruso B; Guidi GC
    Clin Chim Acta; 2013 Nov; 426():33-40. PubMed ID: 23981842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and causes of lipemia interference of clinical chemistry laboratory tests.
    Mainali S; Davis SR; Krasowski MD
    Pract Lab Med; 2017 Aug; 8():1-9. PubMed ID: 28856220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An innovative method for determining lipemia interference in blood specimens.
    Rosenthal MA; Katz HB
    Clin Chim Acta; 2011 Mar; 412(7-8):665-7. PubMed ID: 21108941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Interference of Lipemia on Routine Clinical Biochemical Tests.
    ArulVijayaVani S; Mohanraj PS; Reeta R
    J Lab Physicians; 2023 Jun; 15(2):269-275. PubMed ID: 37323607
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the interference of hemoglobin, bilirubin, and lipids on Roche Cobas 6000 assays.
    Ji JZ; Meng QH
    Clin Chim Acta; 2011 Aug; 412(17-18):1550-3. PubMed ID: 21575617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of lipemia interference created with native lipemic material and intravenous lipid emulsion in emergency laboratory tests.
    Çolak Samsum E; Sürer H; Bolat S; Şeneş M; Yücel D
    Biochem Med (Zagreb); 2024 Jun; 34(2):020701. PubMed ID: 38665874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.